Skip to main content

The Baveno IV Workshop: European Consensus Meeting on Portal Hypertension and Comparison with Japanese Guidelines

  • Chapter
  • First Online:
Clinical Investigation of Portal Hypertension
  • 1017 Accesses

Abstract

In this chapter introducing the results of the discussions that took place in the consensus meeting on portal hypertension held on April 10–11, 2015 in Baveno, Italy, the Japanese guidelines published in 2016 are compared with the Baveno consensus on portal hypertension. The Baveno VI workshop honors the 25th anniversary of its organizer Prof. Roberto de Franchis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Franchis R, editor. Portal hypertension VI: proceedings of the sixth Baveno consensus workshop; stratifying risk and individualizing care. Springer; 2016.

    Google Scholar 

  2. Tsochatzis EA, Bosch J, Burrough AK. Liver cirrhosis. Lancet. 2014;383(9930):1749–61.

    Article  Google Scholar 

  3. Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension. J Hepatol. 2015;63:743–52.

    Article  Google Scholar 

  4. Thabut D, Rudler M, Dib N, Carbonell N, Mathurin P, Saliba F, et al. Multicenter prospective validation of Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding. Hepatology. 2015;61:1024–32.

    Article  CAS  Google Scholar 

  5. Ahn SY, Park SY, Tak WY, Lee YR, Kang EJ, Park JG, et al. Prospective validation of Baveno V definitions and criteria for failure to control bleeding in portal hypertension. Hepatology. 2015;61:1033–40.

    Article  Google Scholar 

  6. Jepsen P, Vilstrup H, Andersen PK. The clinical course of cirrhosis; the importance of multi-state models and competing analysis. Hepatology. 2015;62(1):292–302. https://doi.org/10.1002/hep.27598.

    Article  PubMed  Google Scholar 

  7. Jepsen P. Comorbidity in cirrhosis. World J Gastroenterol. 2014;20:7223–30.

    Article  Google Scholar 

  8. Kudo M, Shiina T, Moriyasu F, Iijima H, Tateishi R, Yada N, et al. JSUM ultrasound elastography practice guidelines: liver. J Med Ultrason. 2013;40:325–57.

    Article  Google Scholar 

  9. Villa E, Camma C, Marietta M, Luongo M, Critelli R, Colopi S, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology. 2012;143:1253–60.

    Article  CAS  Google Scholar 

  10. Vlachogiannakos J, Viazis N, Vasianopoulou P, Vafiadis I, Karamanolis DG, Ladas SD. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis. J Gastroenterol Hepatol. 2013;28(3):450–5.

    Article  CAS  Google Scholar 

  11. Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol. 2016;51:629–50.

    Article  CAS  Google Scholar 

  12. Iso Y, Kawanaka H, Tomikawa M. Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices; a prospective randomized trial. Hepato-Gastroenterology. 1997;44:467–71.

    CAS  PubMed  Google Scholar 

  13. Gotoh Y, Iwakiri R, Sakata Y, Koyama T, Noda T, Matsunaga C, et al. Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices; a prospective, controlled trial compared with endoscopic injection sclerotherapy. J Gastroenterol Hepatol. 1999;14:241–4.

    Article  CAS  Google Scholar 

  14. Akahoshi T, Tomikawa M, Tsutsumi N, Hashizume M, Maehara Y. Merits of prophylactic sclerotherapy for esophageal varices concomitant unresectable hepatocellular carcinoma; prospective randomized study. Dig Endosc. 2014;26:172–7.

    Article  Google Scholar 

  15. Sauerbruch T, Mengel M, Dollinger M, et al. German Study Group for Prophylaxis of Variceal Rebleeding. Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy. Gastroenterology. 2015;149(3):528–31.

    Article  Google Scholar 

  16. Sabri SS, Abi-Jaoudeh N, Swee W, Saad WE, Turba UC, Caldwell SH, et al. Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration. J Vasc Interv Radiol. 2014;25:355–61.

    Article  Google Scholar 

  17. Lee SJ, Kim SU, Kim MD, Kim YH, Kim GM, Park SI, et al. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis. J Gastroenterol Hepatol. 2017;32(8):1487–94. https://doi.org/10.1111/jgh.13729.

    Article  PubMed  Google Scholar 

  18. Kobayakawa M, Kokubu S, Hirota S, Koizumi J, Nishida N, Yasumoto T, et al. Short-term safety and efficacy of balloon-occluded retrograde transvenous obliteration using ethanolamine oleate; results of a prospective, multicenter, single-arm trial. J Vasc Interv Radiol. 2017;28(8):1108–15. https://doi.org/10.1016/j.jvir.2017.03.041. pii: S1051-0443(17)30378-0

    Article  PubMed  Google Scholar 

  19. Hubmann R, Bodlaj G, Czompo M, Benko L, Pichler P, Al-Kathib S, et al. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy. 2006;38:896–901.

    Article  CAS  Google Scholar 

  20. Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071–81.

    Article  CAS  Google Scholar 

  21. Cardenas A, Mendez-Bocanegra A. Report of the Baveno VI consensus workshop. Ann Hepatol. 2016;15:289–90.

    PubMed  Google Scholar 

  22. Park JK, Saab S, Kee ST, Busutti RW, Kim HJ, Durazo F, et al. Balloon-occluded retrograde transvenous obliteration (BRTO) for treatment of gastric varices: review and meta-analysis. Dig Dis Sci. 2015;60:1543–53.

    Article  Google Scholar 

  23. Choi YH, Yoon CJ, Park JH, Chung JW, Kwon JW, Choi GM. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol. 2003;4:109–16.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naoya Murashima .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Murashima, N. (2019). The Baveno IV Workshop: European Consensus Meeting on Portal Hypertension and Comparison with Japanese Guidelines. In: Obara, K. (eds) Clinical Investigation of Portal Hypertension. Springer, Singapore. https://doi.org/10.1007/978-981-10-7425-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-7425-7_16

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-7424-0

  • Online ISBN: 978-981-10-7425-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics